search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Subclonal immune evasion in non-small cell lung cancer.

Krijn K Dijkstra ,
Roberto Vendramin ,
Despoina Karagianni ,
Maartje Witsen ,
Felipe Gálvez-Cancino ,
Mark S Hill ,
Kane A Foster ,
Vittorio Barbè ,
Mihaela Angelova ,
Robert E Hynds ,
David R Pearce ,
Carlos Martínez-Ruiz ,
James R M Black ,
Ariana Huebner ,
Oriol Pich ,
Andrew Rowan ,
Marcellus Augustine ,
Clare Puttick ,
David A Moore ,
Lydia L Liu ,
Sadegh Saghafinia ,
Joris van de Haar ,
Selvaraju Veeriah ,
Cristina Naceur-Lombardelli ,
Antonia Toncheva ,
Supreet Kaur Bola ,
Crispin T Hiley ,
Mariam Jamal-Hanjani ,
Nicholas McGranahan ,
Kevin Litchfield ,
James L Reading ,
Benny Chain ,
,
Sergio A Quezada ,
Emile E Voest ,
Charles Swanton

Abstract

Cancers rarely respond completely to immunotherapy. While tumors consist of multiple genetically distinct clones, whether this affects the potential for immune escape remains unclear due to an inability to isolate and propagate individual subclones from human cancers. Here, we leverage the multi-region TRACERx lung cancer evolution study to generate a patient-derived organoid - T cell co-culture platform that allows the functional analysis of subclonal immune escape at single clone resolution. We establish organoid lines from 11 separate tumor regions from three patients, followed by isolation of 81 individual clonal sublines. Co-culture with tumor infiltrating lymphocytes (TIL) or natural killer (NK) cells reveals cancer-intrinsic and subclonal immune escape in all 3 patients. Immune evading subclones represent genetically distinct lineages with a unique evolutionary history. This indicates that immune evading and non-evading subclones can be isolated from the same tumor, suggesting that subclonal tumor evolution directly affects immune escape.

More about this publication

Cancer cell

Volume 43
Issue nr. 10
Pages 1833-1849.e10
Publication date 13-10-2025

Full text links

Publisher website (DOI) 10.1016/j.ccell.2025.06.012
Europe PubMed Central 40614739
Pubmed 40614739

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.